Amber French
Acute Care · Fredericksburg, VANPI 1124872361
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.3% of the total across 267 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations. Among acute care clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 267 payments — averaging $27.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- GSK$931
- ANI Pharmaceuticals, Inc.$502
- Mallinckrodt Hospital Products Inc.$487
- Sanofi$417
- Regeneron Healthcare Solutions, Inc.$398
- plus $3K from 21 others
What the payments were for
- Food & beverage$7,03195%
- Education$3485%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 52 | $1,552 |
| GSK | 40 | $931 |
| ANI Pharmaceuticals, Inc. | 16 | $502 |
| Mallinckrodt Hospital Products Inc. | 13 | $487 |
| Sanofi | 16 | $417 |
| Regeneron Healthcare Solutions, Inc. | 10 | $398 |
| United Therapeutics Corporation | 11 | $395 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $364 |
| Actelion Pharmaceuticals US, Inc. | 12 | $350 |
| Amgen | 15 | $296 |
| Boehringer Ingelheim | 12 | $292 |
| Insmed, Inc. | 9 | $228 |
| Pulmonx Corporation | 2 | $201 |
| Harmony Biosciences LLC | 5 | $188 |
| Verona Pharma, Inc. | 6 | $121 |
| Electromed, Inc. | 11 | $104 |
| Pfizer | 5 | $101 |
| Viatris Specialty LLC | 4 | $75 |
| Baxter Healthcare | 2 | $65 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $60 |
| Vifor Pharma, Inc. | 3 | $59 |
| Sanofi-aventis U.S. LLC | 1 | $53 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $36 |
| Paratek Pharmaceuticals, Inc. | 2 | $35 |
| Novo Nordisk | 1 | $21 |
| Itamar Medical Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIRSUPRA$319
- TEZSPIRE$308
- NUCALA$238
- FASENRA$201
- CHARTIS CATHETER$167
- ZEPHYR DELIVERY CATHETER$167
- ZEPHYR ENDOBRONCHIAL VALVE$167
- PULMONX CHARTIS TABLET CONSOLE$167
- BREZTRI$129
- DUPIXENT$125
How this compares
$7,378 in reported general payments places this provider in the 95th percentile of 599 acute care providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 37 | $34,635 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 18 | $20,296 |
| Spiriva RespimatTiotropium Bromide | 15 | $17,917 |
| SymbicortBudesonide/Formoterol Fumarate | 15 | $6,818 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 79 | $3,354 |
| Ipratropium Bromide | 33 | $1,460 |
| Fluticasone Propionate | 19 | $558 |
| Prednisone | 69 | $219 |
| Montelukast Sodium | 19 | $147 |
| Azithromycin | 27 | $83 |
| Levocetirizine Dihydrochloride | 11 | $62 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $931 | $34,63537 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $1,552 | $27,11433 claims |
| Boehringer IngelheimSpiriva Respimat | $292 | $17,91715 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 599 acute care providers in Virginia.
Other acute care in Fredericksburg
- Corinnia WagnerFredericksburg$18K
- Vicki WallaceFredericksburg$4K
- Sarah DavalleFredericksburg$4K
- Rachel DukeRichmond$751K
- Julia KingNorfolk$99K
- Sarah KennedyNorfolk$57K
- Sarah W ShermanNorth Chesterfield$41K
- Tamara StephensDeltaville$30K
- Debra CastnerNassawadox$28K
- Linda HartMidlothian$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.